Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Healing II: Complications01:24

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Dermatological Adverse Events Associated With MEK Inhibitors.

Actas dermo-sifiliograficas·2026
Same author

Severe Cutaneous Signs of Hipersensitivity to Drugs in a Pediatric Hospital.

Actas dermo-sifiliograficas·2025
Same author

[Translated article] Four-Year Maintenance of Complete Skin Clearance With Bimekizumab in 10 Spanish Patients from the Be Radiant Trial.

Actas dermo-sifiliograficas·2024
Same author

[Translated article] Real-World Clinical, Psychosocial and Financial Burden of Atopic Dermatitis: Results from the Spanish Cohort of the MEASURE-AD Trial.

Actas dermo-sifiliograficas·2024
Same author

[Translated article] Retrospective Study of Risk Markers for Developing High-Grade Anal Intraepithelial Neoplasm in Men Who Have Sex With Men Living With HIV.

Actas dermo-sifiliograficas·2024
Same author

[Translated article] Consensus on the Diagnostic Algorithm for Chronic Nodular Prurigo.

Actas dermo-sifiliograficas·2024

Related Experiment Video

Updated: May 18, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
06:39

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings

Published on: June 13, 2025

Cutaneous adverse events associated with heparin.

P Maldonado Cid1, R M Alonso de Celada, L Noguera Morel

  • 1Department of Dermatology, Hospital Universitario La Paz, Madrid, Spain. pmaldonadocid@gmail.com

Clinical and Experimental Dermatology
|September 25, 2012
PubMed
Summary

Heparin can cause skin reactions, including immune-mediated lesions and bleeding. This review details these dermatological side effects and offers management strategies for healthcare providers.

More Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

Related Experiment Videos

Last Updated: May 18, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
06:39

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings

Published on: June 13, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Heparin is a widely used anticoagulant.
  • Heparin administration is linked to diverse cutaneous adverse events.

Purpose of the Study:

  • To review and synthesize the literature on heparin-induced dermatological side effects.
  • To provide a management guide for these reactions.

Main Methods:

  • Comprehensive literature search for reported heparin-related skin reactions.
  • Analysis of dermatological manifestations and their underlying mechanisms.
  • Compilation of clinical management strategies.

Main Results:

  • Common reactions include immune-mediated skin lesions (e.g., heparin-induced thrombocytopenia with thrombosis/thrombocytopenia syndrome) and bleeding complications.
  • Less common reactions such as localized reactions, urticaria, and skin necrosis are also discussed.
  • Management varies based on the specific reaction and clinical context.

Conclusions:

  • Healthcare professionals must be vigilant for cutaneous manifestations of heparin therapy.
  • Prompt recognition and appropriate management are crucial to mitigate adverse outcomes.
  • Understanding the spectrum of heparin's dermatological effects improves patient safety.